Company Name: Roche (Philippines) Inc.
Year Started: May 2013
Target Condition: Rheumatoid Arthritis (RA)
Who Is Eligible? The re-ACTnow program is designed for patients diagnosed with Rheumatoid Arthritis who have been prescribed tocilizumab, a biologic treatment for RA.
About the Program
The re-ACTnow Program provides comprehensive support to patients managing Rheumatoid Arthritis to enhance their treatment experience and ensure adherence to their prescribed therapy. Upon enrollment, participants gain access to several benefits aimed at improving patient outcomes:
- Educational Materials. Participants receive patient education resources, delivered via mail, email, or text alerts. These materials include tips on managing RA, understanding treatment, and improving overall health.
- Infusion Assistance. Patients are provided with free infusion materials, along with professional nurse assistance during their treatment sessions, ensuring safety and comfort.
- Discounted Treatment Costs. Enrolled patients enjoy discounts on their prescribed tocilizumab treatments, helping reduce the financial burden of managing a chronic condition.
How to Enroll
To take advantage of the program, patients should consult their rheumatologist, who can provide guidance on enrollment and access to benefits.
Where to Get More Information
For inquiries about the re-ACTnow Program, patients and caregivers can contact the following numbers:
- Hotline: (+632) 718-7622
- Cell Phone: (+63) 917 535 9527
Why Programs Like re-ACTnow Matter
Chronic conditions like Rheumatoid Arthritis can be physically, emotionally, and financially challenging. Programs like re-ACTnow aim to bridge the gap between medical treatment and patient support by addressing common barriers such as high costs and lack of education. By offering personalized assistance, the program empowers patients to adhere to their prescribed therapy and improve their quality of life.
If you or someone you know is managing RA and prescribed tocilizumab, consider exploring the benefits of this program for a more supported and informed treatment journey.
